NCT04748081View on ClinicalTrials.gov

The Major Bleeding Risk Following Hepatectomy

CompletedOBSERVATIONAL
Enrollment

5,265

Participants

Timeline

Start Date

January 1, 2000

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2018

Conditions
Gastrointestinal HemorrhagePostoperative HemorrhageSurgery--Complications
Interventions
PROCEDURE

hepatectomy

hepatectomy (ICD-9-CM procedure code: 50.2, 50.22, 50.3 and 50.4)

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

An-Nan Hospital, China Medical University

OTHER

collaborator

Ministry of Health and Welfare, Taiwan

OTHER_GOV

lead

China Medical University Hospital

OTHER

NCT04748081 - The Major Bleeding Risk Following Hepatectomy | Biotech Hunter | Biotech Hunter